Vicky is one of the creators of CLGdotTV, where she also produces and presents programmes. She has 25 years experience of delivering projects in and for public sector organisations including government departments, local authorities, the NHS, and professional associations. Much of her work has been around digitally-enabled innovation and improvement.


Aston Medical School spinout close to launch of diagnostic and therapies for serious pregnancy condition


© CLGdotTV 2019

May Rezai, a PHD student at Aston University Medical School describes development of MirZyme Therapeutics, a spin out company working on diagnostics and therapies for pre-eclampsia.

Pre-eclampsia (aka ‘the silent killer’) is a condition that affects some pregnant women, usually during the second half of pregnancy. The condition can lead to serious complications for both mother and baby.

MirZyme Therapeutics has been spun out from the Aston Medical School and is based on research work originally carried out by its Dean, Professor Asif Ahmed. The diagnostic is set to be launched in China in 2021, with therapies following three to four years after that.


Back to homepage